Clinical reports of limited and treatable cancer metastases, a disease state that exists in a
transitional zone between localized and widespread systemic disease, were noted on …

Colorectal cancer (CRC) is one of the most common malignancies in Western countries.
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …

Purpose Potentially curative treatment is always the first-line approach in patients with early
cancer. In patients with early liver cancer like hepatocellular carcinoma (HCC), thermal …

BACKROUND Circulating tumor DNA (ctDNA) holds promise as a non-invasive means for
tumor monitoring in solid malignancies. Assays with high sensitivity and multiplexed …

Background Primary tumour location has long been debated as a prognostic factor in
colorectal cancer patients with liver metastases (CRLM) undergoing liver resection. This …

Background Synchronous metastases are considered a negative prognostic factor in
patients with metastatic colorectal cancer (CRC). We investigated the outcomes of stage IV …

GAS5 is abnormally high in colorectal cancer tissues, which is a specific expression of
lncRNA in colorectal cancer (CRC). Nevertheless, its biological function in CRC has not …

Background The definition of R1 resection in colorectal cancer liver metastases (CRLM)
remains debatable. This retrospective study was conducted to clarify the impact of R1 …

Background Oligometastasis is a good prognostic indicator when compared to widely
metastatic disease in malignancies of other organ systems. We hypothesized that …

In the United States of America, almost 150,000 people are estimated to be diagnosed with
colorectal cancer in 2020 and up to 35% of those are expected to present with …